Financial Life Planners’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$462 Hold
49
﹤0.01% 306
2026
Q1
$399 Buy
+49
New +$444 ﹤0.01% 334
2025
Q4
Sell
-49
Closed -$425 243
2025
Q3
$425 Buy
+49
New +$381 ﹤0.01% 328
2025
Q1
Sell
-49
Closed -$394 282
2024
Q4
$394 Buy
+49
New +$472 ﹤0.01% 370

Other funds holding NVAX

Financial Life Planners's NVAX Position: Q2 2026 in Review

Financial Life Planners held its Novavax (NVAX) position steady in Q2 2026 at 49 shares worth $462. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Financial Life Planners first reported a position in NVAX in Q4 2024 and has held it in 4 quarters since. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Financial Life Planners held 49 shares of Novavax worth $462 as of Q2 2026.
  • Financial Life Planners left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of Financial Life Planners's portfolio in Q2 2026, its #306 holding.
  • Financial Life Planners first reported a position in Novavax in Q4 2024 and has held it in 4 quarters since.
  • 64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Financial Life Planners's 13F filing for Q2 2026, filed 21 Jul 2026.